Literature DB >> 29332990

Order preservation of expected information content using Unscented Transform approximation of multivariate prior distributions in HIV 2-LTR experiment design.

George Abraham1, Aditya Jagarapu2, Lamont Cannon2, Ryan Zurakowski2.   

Abstract

Numerical computation of the expected information content of a prospective experimental design is computationally expensive, requiring calculating the Kullback-Leibler divergence of the posterior distribution from the prior for simulated data from a large sample of points from the prior distribution. In this work, we investigate whether the Unscented Transform (UT) of the prior distribution can provide an adequate estimate of the expected information content in the context of experiment design for a previously validated HIV-1 2-LTR model. Three different schedules with evenly distributed time points have been used to generate the experimental data along with the incorporation of qPCR noise for the study. The UT shows promise in estimating information content by preserving the optimal ordering of 2-LTR sample collection schedules, when compared to completely stochastic sampling from the underlying multivariate distributions.

Entities:  

Year:  2016        PMID: 29332990      PMCID: PMC5761742          DOI: 10.1109/CDC.2016.7799129

Source DB:  PubMed          Journal:  Proc IEEE Conf Decis Control        ISSN: 0743-1546


  20 in total

1.  Measuring covert HIV replication during HAART: the abundance of 2-LTR circles is not a reliable marker.

Authors:  Frederic Bushman
Journal:  AIDS       Date:  2003-03-28       Impact factor: 4.177

2.  Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication.

Authors:  Theodore C Pierson; Tara L Kieffer; Christian T Ruff; Christopher Buck; Stephen J Gange; Robert F Siliciano
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapy.

Authors:  Rajesh T Gandhi; Robert W Coombs; Ellen S Chan; Ronald J Bosch; Lu Zheng; David M Margolis; Sarah Read; Beatrice Kallungal; Ming Chang; Erin A Goecker; Ann Wiegand; Mary Kearney; Jeffrey M Jacobson; Richard D'Aquila; Michael M Lederman; John W Mellors; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2012-03-01       Impact factor: 3.731

4.  Reliable and reproducible LightCycler qPCR for HIV-1 DNA 2-LTR circles.

Authors:  I A Teo; J Morlese; J W Choi; S Shaunak
Journal:  J Immunol Methods       Date:  2002-12-01       Impact factor: 2.303

5.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

6.  Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS.

Authors:  L A Panther; R W Coombs; J E Zeh; A C Collier; L Corey
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-04-01

7.  Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.

Authors:  Audrey Brussel; Dominique Mathez; Sophie Broche-Pierre; Rémi Lancar; Thierry Calvez; Pierre Sonigo; Jacques Leibowitch
Journal:  AIDS       Date:  2003-03-28       Impact factor: 4.177

8.  Identification of two mutually exclusive groups after long-term monitoring of HIV DNA 2-LTR circle copy number in patients on HAART.

Authors:  John Morlese; Ian A Teo; Ji-won Choi; Brian Gazzard; Sunil Shaunak
Journal:  AIDS       Date:  2003-03-28       Impact factor: 4.177

9.  2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo.

Authors:  C D Pauza; P Trivedi; T S McKechnie; D D Richman; F M Graziano
Journal:  Virology       Date:  1994-12       Impact factor: 3.616

10.  Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Authors:  Hiroyu Hatano; Matthew C Strain; Rebecca Scherzer; Peter Bacchetti; Deborah Wentworth; Rebecca Hoh; Jeffrey N Martin; Joseph M McCune; James D Neaton; Russell P Tracy; Priscilla Y Hsue; Douglas D Richman; Steven G Deeks
Journal:  J Infect Dis       Date:  2013-08-23       Impact factor: 5.226

View more
  2 in total

1.  Implications of Measurement Assay Type in Design of HIV Experiments.

Authors:  LaMont Cannon; Aditya Jagarapu; Cesar A Vargas-Garcia; Michael J Piovoso; Ryan Zurakowski
Journal:  Proc IEEE Conf Decis Control       Date:  2018-01-23

2.  HIV 2-LTR experiment design optimization.

Authors:  LaMont Cannon; Cesar A Vargas-Garcia; Aditya Jagarapu; Michael J Piovoso; Ryan Zurakowski
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.